Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria

NCT02807974 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: CS-3150

Sponsor

Daiichi Sankyo Co., Ltd.